Ajmer S. Grewal

Yamunanagar, HR 135001, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Dual SYK-HDAC Inhibitor Elicits Striking Efficacy against Acute Myeloid Leukemia: Rational Design, Synthesis, and Biological Evaluation.

Dual SYK-HDAC Inhibitor Elicits Striking Efficacy against Acute Myeloid Leukemia: Rational Design, Synthesis, and Biological Evaluation.

Journal: Journal of medicinal chemistry

Published: June 09, 2026

(E)-4-(4-Acrylamidophenoxy)-N-Methylpicolinamides as b-Raf/VEGFR-2 Inhibitors with Antiangiogenic Activity in HUVEC and Zebrafish Model.

(E)-4-(4-Acrylamidophenoxy)-N-Methylpicolinamides as b-Raf/VEGFR-2 Inhibitors with Antiangiogenic Activity in HUVEC and Zebrafish Model.

Journal: Molecules (Basel, Switzerland)

Published: February 12, 2026

Plant-Derived Nanostructured Drug Delivery Systems for Attenuating Chronic Obstructive Pulmonary Diseases: Raising Concerns, Recent Trends, and Comparative Advancements.

Plant-Derived Nanostructured Drug Delivery Systems for Attenuating Chronic Obstructive Pulmonary Diseases: Raising Concerns, Recent Trends, and Comparative Advancements.

Journal: Current drug delivery

Published: August 04, 2025

Advances in Microneedle Technology for Targeted Therapy in Alzheimer's and Parkinson's Disease.

Advances in Microneedle Technology for Targeted Therapy in Alzheimer's and Parkinson's Disease.

Journal: Current drug delivery

Published: June 28, 2025

Neuroprotective Marine Bioactives in Paediatric ADHD: A Focused Review on Therapeutic Potential.

Neuroprotective Marine Bioactives in Paediatric ADHD: A Focused Review on Therapeutic Potential.

Journal: CNS & neurological disorders drug targets

Published: June 22, 2025

Integrated In silico and In vitro Screening of Phytoconstituents as Potential Inhibitors of New Delhi Metallo-β-lactamase-1 (NDM-1).

Integrated In silico and In vitro Screening of Phytoconstituents as Potential Inhibitors of New Delhi Metallo-β-lactamase-1 (NDM-1).

Journal: Current pharmaceutical biotechnology

Published: May 31, 2025

Olaparib-Cediranib Hybrid as Dual PARP-VEGFR3 Inhibitor Elicits Antitumor Efficacy: Rational Design, Synthesis, Biological Evaluation and Construction of a Charge Convertible pH Responsive Nanoformulation.

Olaparib-Cediranib Hybrid as Dual PARP-VEGFR3 Inhibitor Elicits Antitumor Efficacy: Rational Design, Synthesis, Biological Evaluation and Construction of a Charge Convertible pH Responsive Nanoformulation.

Journal: Bioorganic chemistry

Published: April 15, 2025

Therapeutic Insights into Natural Products for Modulating Neurodegenerative Disease Pathways.

Therapeutic Insights into Natural Products for Modulating Neurodegenerative Disease Pathways.

Journal: Central nervous system agents in medicinal chemistry

Published: April 07, 2025

Molecular dynamics simulations: Insights into protein and protein ligand interactions.

Molecular dynamics simulations: Insights into protein and protein ligand interactions.

Journal: Advances in pharmacology (San Diego, Calif.)

Published: April 02, 2025

Oroidins: Marine Pyrrole-Imidazole Alkaloids with Emerging Therapeutic Potential.

Oroidins: Marine Pyrrole-Imidazole Alkaloids with Emerging Therapeutic Potential.

Journal: Current topics in medicinal chemistry

Published: March 10, 2025

Role of Major Bioactive Compounds in the Treatment of Anti-aging and Skincare: A Review.

Role of Major Bioactive Compounds in the Treatment of Anti-aging and Skincare: A Review.

Journal: Current pharmaceutical biotechnology

Published: February 06, 2025

Maternal Embryonic Leucine Zipper Kinase (MELK) as a Promising Therapeutic Target in Triple Negative Breast Cancer.

Maternal Embryonic Leucine Zipper Kinase (MELK) as a Promising Therapeutic Target in Triple Negative Breast Cancer.

Journal: Anti-cancer agents in medicinal chemistry

Published: February 01, 2025

Showing 1-12 of 58

Last Updated: 09/26/2026